Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

News

“Switching off” the ovaries reduces the risk of breast cancer recurrence by one-fifth in younger women

Study shows suppressing ovarian function can significantly lower breast cancer recurrence risk in younger women already taking tamoxifen.

Photo of a hospital ward. Image is focus on pinned paper written 'Recovery Trial'.

RECOVERY trial hailed as one of the two success stories of the COVID-19 pandemic

The Chair of the COVID-19 Inquiry has described the RECOVERY trial’s identification of the drug dexamethasone as ‘one of the two success stories of the pandemic’.

Excess weight in early adulthood linked to higher risk of premature death

Research published in Science Bulletin links excess weight in early adulthood to increased risk of premature death.

Statins do not cause the majority of side effects listed in package leaflets

New report highlights major advances that could transform outcomes for people with chronic kidney disease

Long-term trial results show surgery and stenting are equally protective against stroke

Weight loss alone doesn’t ease atrial fibrillation symptoms in older adults, study finds

Home-based heart rhythm screening improves diagnosis of common heart condition

Professor Sir Rory Collins outside the Richard Doll Building

Rory Collins awarded Royal Society’s Buchanan Medal

A 3D medical illustration of breast cancer

Continuing hormone treatment with aromatase inhibitors beyond five years further reduces the risk of breast cancer recurrence by a quarter in postmenopausal women

Empagliflozin is a cost-effective treatment for people with chronic kidney disease

Study links different genetic pathways causing irregular heartbeats to different risks of stroke

Emeritus Professor Colin Baigent

Emeritus Professor Colin Baigent wins prestigious European Renal Association award

Latin-American genetic data available securely to approved researchers worldwide/Datos genéticos latinoamericanos disponibles para investigadores de todo el mundo

Study uncovers proteins associated with Alzheimer’s and other neurodegenerative diseases

Image of a ECG in the shape of a heart.

Research highlights the critical role of GP data in understanding common heart condition

Understanding blood proteins can improve risk prediction for heart attacks

Image of alcohol bottles on shelves in a shop,

Higher alcohol consumption, binge drinking, and very high percentage alcoholic products increase risk of death in Mexican adults / Mayor consumo de alcohol, el consumo episódico excesivo y los productos de alto porcentaje de alcohol aumentan el riesgo de muerte en adultos mexicanos

People living with chronic kidney disease may benefit more from longer-term use of -flozins

Image of kidneys.

New trial to test potential treatment for chronic kidney disease

Load More